Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Alscher, DM; Biegger, D; Mettang, T; Dunst, R; Wolken, D; Kuhlmann, U; Fritz, P
   Peritoneal metallothionein content in patients with end-stage renal disease on or not on peritoneal dialysis
   PERITONEAL DIALYSIS INTERNATIONAL
   
   D.M. Alscher et al., "Peritoneal metallothionein content in patients with end-stage renal disease on or not on peritoneal dialysis", PERIT DIA I, 21(1), 2001, pp. 92-94
2. Alscher, DM; Mettang, T; Kuhlmann, U
   Cure of lifelong fatigue by calcium supplementation
   LANCET
   
   D.M. Alscher et al., "Cure of lifelong fatigue by calcium supplementation", LANCET, 358(9285), 2001, pp. 888-888
3. Pauli-Magnus, C; Murdter, T; Godel, A; Mettang, T; Eichelbaum, M; Klotz, U; Fromm, MF
   P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin
   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
   
   C. Pauli-Magnus et al., "P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin", N-S ARCH PH, 363(3), 2001, pp. 337-343
4. Pauli-Magnus, C; Mikus, G; Alscher, DM; Kirschner, T; Nagel, W; Gugeler, N; Risler, T; Berger, ED; Kuhlmann, U; Mettang, T
   Naltrexone does not relieve uremic pruritus: Results of a randomized, double-blind, placebo-controlled crossover study
   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
   
   C. Pauli-Magnus et al., "Naltrexone does not relieve uremic pruritus: Results of a randomized, double-blind, placebo-controlled crossover study", J AM S NEPH, 11(3), 2000, pp. 514-519
5. Alscher, DM; Hupp, T; Mettang, T; Kuhlmann, U
   A patient with hypertension was cured after resection of a renal AV fistula
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   D.M. Alscher et al., "A patient with hypertension was cured after resection of a renal AV fistula", NEPH DIAL T, 15(2), 2000, pp. 249-250
6. Mettang, T; Schwab, M; Pauli-Magnus, C; Alscher, DM; Kuhlmann, U
   Pruritus and anemia in a patient on peritoneal dialysis - Pitfalls in diagnosis for common symptoms
   PERITONEAL DIALYSIS INTERNATIONAL
   
   T. Mettang et al., "Pruritus and anemia in a patient on peritoneal dialysis - Pitfalls in diagnosis for common symptoms", PERIT DIA I, 20(6), 2000, pp. 785-787
7. Pauli-Magnus, C; Klumpp, S; Alscher, DM; Kuhlmann, U; Mettang, T
   Short-term efficacy of tacrolimus ointment in severe uremic pruritus
   PERITONEAL DIALYSIS INTERNATIONAL
   
   C. Pauli-Magnus et al., "Short-term efficacy of tacrolimus ointment in severe uremic pruritus", PERIT DIA I, 20(6), 2000, pp. 802-803
8. Mettang, T; Pauli-Magnus, C
   The pathophysiological puzzle of uremic pruritus - Insights and speculations from therapeutic and epidemiological studies
   PERITONEAL DIALYSIS INTERNATIONAL
   
   T. Mettang e C. Pauli-Magnus, "The pathophysiological puzzle of uremic pruritus - Insights and speculations from therapeutic and epidemiological studies", PERIT DIA I, 20(5), 2000, pp. 493-494
9. Mettang, T; Pauli-Magnus, C; Kuhlmann, U
   "Sick-bag" syndrome
   PERITONEAL DIALYSIS INTERNATIONAL
   
   T. Mettang et al., ""Sick-bag" syndrome", PERIT DIA I, 20(2), 2000, pp. 243-243
10. Mettang, T; Pauli-Magnus, C; Alscher, DM; Kirchgessner, J; Wodarz, R; Rettenmeier, AW; Kuhlmann, U
    Influence of plasticizer-free CAPD bags and tubings on serum, urine, and dialysate levels of phthalic acid esters in CAPD patients
    PERITONEAL DIALYSIS INTERNATIONAL
    
    T. Mettang et al., "Influence of plasticizer-free CAPD bags and tubings on serum, urine, and dialysate levels of phthalic acid esters in CAPD patients", PERIT DIA I, 20(1), 2000, pp. 80-84
11. Alscher, DM; Pauli-Magnus, C; Kuhlmann, U; Mettang, T
    Stimulated IFN gamma and IL-10 secretion of blood mononuclear cells in patients on renal replacement therapies show different secretion patterns
    ARTIFICIAL ORGANS
    
    D.M. Alscher et al., "Stimulated IFN gamma and IL-10 secretion of blood mononuclear cells in patients on renal replacement therapies show different secretion patterns", ARTIF ORGAN, 24(10), 2000, pp. 767-772
12. Alscher, DM; Pauli-Magnus, C; Kirchgessner, J; Kuhlmann, U; Mettang, T
    A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: Effect on peripheral leukocyte function
    NEPHRON
    
    D.M. Alscher et al., "A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: Effect on peripheral leukocyte function", NEPHRON, 86(1), 2000, pp. 62-69
13. Pauli-Magnus, C; von Richter, O; Burk, O; Ziegler, A; Mettang, T; Eichelbaum, M; Fromm, MF
    Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    C. Pauli-Magnus et al., "Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein", J PHARM EXP, 293(2), 2000, pp. 376-382
14. Dunst, R; Mettang, T; Kuhlmann, U
    Hantavirus infections
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    R. Dunst et al., "Hantavirus infections", DEUT MED WO, 125(28-29), 2000, pp. 875-880
15. Pauli-Magnus, C; Hofmann, U; Mikus, G; Kuhlmann, U; Mettang, T
    Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    C. Pauli-Magnus et al., "Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis", NEPH DIAL T, 14(4), 1999, pp. 903-909
16. Thomas, S; Fischer, FP; Mettang, T; Pauli-Magnus, C; Weber, J; Kuhlmann, U
    Effects of L-carnitine on leukocyte function and viability in hemodialysispatients: A double-blind randomized trial
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    S. Thomas et al., "Effects of L-carnitine on leukocyte function and viability in hemodialysispatients: A double-blind randomized trial", AM J KIDNEY, 34(4), 1999, pp. 678-687
17. Pauli-Magnus, C; Mettang, T; Kuhlmann, U
    Acute renal failure in a patient with lupus-associated membranous nephropathy and severe nephrotic syndrome
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    C. Pauli-Magnus et al., "Acute renal failure in a patient with lupus-associated membranous nephropathy and severe nephrotic syndrome", DEUT MED WO, 124(25-26), 1999, pp. 788-792
18. METTANG T; FISCHER FP; DOLLENBACHER U; KUHLMAN U
    UREMIC PRURITUS IS NOT RELATED TO BETA-ENDORPHIN SERUM LEVELS IN HEMODIALYSIS-PATIENTS
    Nephrology, dialysis, transplantation
    
    T. Mettang et al., "UREMIC PRURITUS IS NOT RELATED TO BETA-ENDORPHIN SERUM LEVELS IN HEMODIALYSIS-PATIENTS", Nephrology, dialysis, transplantation, 13(1), 1998, pp. 231-232
19. Fischer, FP; Machleidt, C; Rettenmeier, AW; Kuhlmann, U; Mettang, T
    Plasticizers and inhibition of leukocyte function in vitro
    PERITONEAL DIALYSIS INTERNATIONAL
    
    F.P. Fischer et al., "Plasticizers and inhibition of leukocyte function in vitro", PERIT DIA I, 18(6), 1998, pp. 620-625
20. Alscher, DM; Pfinder-Nohe, E; Rumpf, D; Pauli-Magnus, C; Knabbe, C; Kuhlmann, U; Mettang, T
    Moulds in containers with biological wastes as a possible source of peritonitis in two patients on peritoneal dialysis
    PERITONEAL DIALYSIS INTERNATIONAL
    
    D.M. Alscher et al., "Moulds in containers with biological wastes as a possible source of peritonitis in two patients on peritoneal dialysis", PERIT DIA I, 18(6), 1998, pp. 643-646
21. DUNST R; METTANG T; KUHLMANN U
    SEVERE THROMBOCYTOPENIA AND RESPONSE TO CORTICOSTEROIDS IN A CASE OF NEPHROPATHIA-EPIDEMICA
    American journal of kidney diseases
    
    R. Dunst et al., "SEVERE THROMBOCYTOPENIA AND RESPONSE TO CORTICOSTEROIDS IN A CASE OF NEPHROPATHIA-EPIDEMICA", American journal of kidney diseases, 31(1), 1998, pp. 116-120
22. METTANG T; FISCHER FP; DUNST R; KUHLMANN U; RETTENMEIER AW
    PLASTICIZERS IN RENAL-FAILURE - ASPECTS OF METABOLISM AND TOXICITY
    Peritoneal dialysis international
    
    T. Mettang et al., "PLASTICIZERS IN RENAL-FAILURE - ASPECTS OF METABOLISM AND TOXICITY", Peritoneal dialysis international, 17, 1997, pp. 31-36
23. RETTENMEIER AW; METTANG T
    PVC-PLASTICIZER DEHP - ASPECTS OF METABOL ISM AND TOXICITY
    Nieren- und Hochdruckkrankheiten
    
    A.W. Rettenmeier e T. Mettang, "PVC-PLASTICIZER DEHP - ASPECTS OF METABOL ISM AND TOXICITY", Nieren- und Hochdruckkrankheiten, 26, 1997, pp. 2-6
24. METTANG T; FISCHER FP; KUHLMANN U; RETTENMEIER AW
    PLASTICIZERS IN PATIENTS WITH END-STAGE R ENAL-FAILURE - ASPECTS OF EXPOSITION AND TOXICITY
    Nieren- und Hochdruckkrankheiten
    
    T. Mettang et al., "PLASTICIZERS IN PATIENTS WITH END-STAGE R ENAL-FAILURE - ASPECTS OF EXPOSITION AND TOXICITY", Nieren- und Hochdruckkrankheiten, 26, 1997, pp. 7-12
25. THOMAS S; SCHENK U; FISCHER FP; METTANG T; PASSLICKDEETJEN J; KUHLMANN U
    IN-VITRO EFFECTS OF GLUCOSE POLYMER-CONTAINING PERITONEAL-DIALYSIS FLUIDS ON PHAGOCYTIC-ACTIVITY
    American journal of kidney diseases
    
    S. Thomas et al., "IN-VITRO EFFECTS OF GLUCOSE POLYMER-CONTAINING PERITONEAL-DIALYSIS FLUIDS ON PHAGOCYTIC-ACTIVITY", American journal of kidney diseases, 29(2), 1997, pp. 246-253
26. METTANG T; THOMAS S; KUHLMANN U
    L-CARNITINE DOES NOT ALLEVIATE UREMIC PRURITUS IN HEMODIALYSIS-PATIENTS
    Nephron
    
    T. Mettang et al., "L-CARNITINE DOES NOT ALLEVIATE UREMIC PRURITUS IN HEMODIALYSIS-PATIENTS", Nephron, 75(3), 1997, pp. 372-372
27. METTANG T; THOMAS S; MACHLEIDT C; FISCHER FP; KUHLMANN U; RETTENMEIER AW
    UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS
    Journal of the American Society of Nephrology
    
    T. Mettang et al., "UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS", Journal of the American Society of Nephrology, 7(9), 1996, pp. 1213-1213
28. METTANG T; THOMAS S; KIEFER T; FISCHER FP; KUHLMANN U; WODARZ R; RETTENMEIER AW
    UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS
    Nephrology, dialysis, transplantation
    
    T. Mettang et al., "UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS", Nephrology, dialysis, transplantation, 11(12), 1996, pp. 2439-2443
29. METTANG T; THOMAS S; KIEFER T; FISCHER FP; KUHLMANN U; WODARZ R; RETTENMEIER AW
    THE FATE OF LEACHED DI(2-ETHYLHEXYL)PHTHALATE IN PATIENTS UNDERGOING CAPD TREATMENT
    Peritoneal dialysis international
    
    T. Mettang et al., "THE FATE OF LEACHED DI(2-ETHYLHEXYL)PHTHALATE IN PATIENTS UNDERGOING CAPD TREATMENT", Peritoneal dialysis international, 16(1), 1996, pp. 58-62
30. METTANG T; SCHENK U; THOMAS S; MACHLEIDT C; KIEFER T; FISCHER FP; KUHLMANN U
    LOW-DOSE INTRADERMAL VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION IN PATIENTS WITH END-STAGE RENAL-FAILURE - A PRELIMINARY-STUDY
    Nephron
    
    T. Mettang et al., "LOW-DOSE INTRADERMAL VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION IN PATIENTS WITH END-STAGE RENAL-FAILURE - A PRELIMINARY-STUDY", Nephron, 72(2), 1996, pp. 192-196
31. MAGADUM S; METTANG T; MEINKE J; KUHLMANN U
    STERNOCOSTOCLAVICULAR HYPEROSTOSIS
    Deutsche Medizinische Wochenschrift
    
    S. Magadum et al., "STERNOCOSTOCLAVICULAR HYPEROSTOSIS", Deutsche Medizinische Wochenschrift, 121(48), 1996, pp. 1492-1497
32. METTANG T; FISCHER FP; KUHLMANN U
    UREMIC PRURITUS - PATHOPHYSIOLOGY AND THE RAPEUTICS
    Deutsche Medizinische Wochenschrift
    
    T. Mettang et al., "UREMIC PRURITUS - PATHOPHYSIOLOGY AND THE RAPEUTICS", Deutsche Medizinische Wochenschrift, 121(33), 1996, pp. 1025-1031
33. MORIKE K; MAGADUM S; METTANG T; GRIESE EU; MACHLEIDT C; KUHLMANN U
    PROPAFENONE IN A USUAL DOSE PRODUCES SEVERE SIDE-EFFECTS - THE IMPACTOF GENETICALLY-DETERMINED METABOLIC STATUS ON DRUG-THERAPY
    Journal of internal medicine
    
    K. Morike et al., "PROPAFENONE IN A USUAL DOSE PRODUCES SEVERE SIDE-EFFECTS - THE IMPACTOF GENETICALLY-DETERMINED METABOLIC STATUS ON DRUG-THERAPY", Journal of internal medicine, 238(5), 1995, pp. 469-472
34. FISCHER FP; SCHENK U; KIEFER T; HUBEL E; THOMAS S; YATZIDIS H; METTANG T; KUHLMANN U
    IN-VITRO EFFECTS OF BICARBONATE-BUFFERED VERSUS LACTATE-BUFFERED CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS FLUIDS ON PERITONEAL MACROPHAGE FUNCTION
    American journal of kidney diseases
    
    F.P. Fischer et al., "IN-VITRO EFFECTS OF BICARBONATE-BUFFERED VERSUS LACTATE-BUFFERED CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS FLUIDS ON PERITONEAL MACROPHAGE FUNCTION", American journal of kidney diseases, 26(6), 1995, pp. 924-933
35. KIEFER T; SCHENK U; HUBEL E; WEBER J; METTANG T; PASSLICKDEETJEN J; KUHLMANN U
    IN-VITRO EFFECTS OF LOW-CALCIUM PERITONEAL-DIALYSIS SOLUTIONS ON PERITONEAL MACROPHAGE FUNCTIONS
    American journal of kidney diseases
    
    T. Kiefer et al., "IN-VITRO EFFECTS OF LOW-CALCIUM PERITONEAL-DIALYSIS SOLUTIONS ON PERITONEAL MACROPHAGE FUNCTIONS", American journal of kidney diseases, 25(5), 1995, pp. 751-760
36. METTANG T; THOMAS S; KIEFER T; SCHENK U; FISCHER FP; MACHLEIDT C; KUHLMANN U
    INTRADERMAL (ID) VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION (HEP-B-VAC) IN PATIENTS WITH END-STAGE RENAL-FAILURE (ESRD)
    Journal of the American Society of Nephrology
    
    T. Mettang et al., "INTRADERMAL (ID) VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION (HEP-B-VAC) IN PATIENTS WITH END-STAGE RENAL-FAILURE (ESRD)", Journal of the American Society of Nephrology, 5(3), 1994, pp. 338-338
37. THOMAS S; SCHENK U; FISCHER FP; METTANG T; KUHLMANN U; PASSLICKDEETJEN J
    THE INFLUENCE OF GLUCOSE-POLYMER (GP)-CONTAINING PERITONEAL-DIALYSIS FLUIDS (PDF) VERSUS GLUCOSE (GLU)-CONTAINING PDF ON PHAGOCYTIC CAPACITY
    Journal of the American Society of Nephrology
    
    S. Thomas et al., "THE INFLUENCE OF GLUCOSE-POLYMER (GP)-CONTAINING PERITONEAL-DIALYSIS FLUIDS (PDF) VERSUS GLUCOSE (GLU)-CONTAINING PDF ON PHAGOCYTIC CAPACITY", Journal of the American Society of Nephrology, 5(3), 1994, pp. 427-427
38. SCHENK U; KIEFER T; HUBEL E; WEBER J; METTANG T; PASSLICKDEETJEN J; KUHLMANN U
    IN-VITRO EFFECTS OF AMINO-ACID-BASED VERSUS GLUCOSE-BASED CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS FLUIDS ON PERITONEAL MACROPHAGE FUNCTION
    Nephron
    
    U. Schenk et al., "IN-VITRO EFFECTS OF AMINO-ACID-BASED VERSUS GLUCOSE-BASED CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS FLUIDS ON PERITONEAL MACROPHAGE FUNCTION", Nephron, 68(3), 1994, pp. 338-346
39. WEBER J; METTANG T; HUBEL E; KIEFER T; KUHLMANN U
    SURVIVAL OF 138 SURGICALLY PLACED STRAIGHT DOUBLE-CUFF TENCKHOFF CATHETERS IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    Peritoneal dialysis international
    
    J. Weber et al., "SURVIVAL OF 138 SURGICALLY PLACED STRAIGHT DOUBLE-CUFF TENCKHOFF CATHETERS IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS", Peritoneal dialysis international, 13(3), 1993, pp. 224-227
40. METTANG T; WEBER J; SCHENK U; MACHLEIDT C; KUHLMANN U
    INTRADERMAL HEPATITIS-B VACCINATION IN NONRESPONSIVE HEMODIALYSIS-PATIENTS
    Renal failure
    
    T. Mettang et al., "INTRADERMAL HEPATITIS-B VACCINATION IN NONRESPONSIVE HEMODIALYSIS-PATIENTS", Renal failure, 15(5), 1993, pp. 655-656
41. METTANG T; FRITZ P; WEBER J; MACHLEIDT C; HUBEL E; KIEFER T; KUHLMANN U
    EPIDERMAL LANGERHANS CELLS IN UREMIC PATIENTS ON HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    Nephron
    
    T. Mettang et al., "EPIDERMAL LANGERHANS CELLS IN UREMIC PATIENTS ON HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS", Nephron, 65(2), 1993, pp. 278-283